Gilead begins UK trials of COVID-19 drug remdesivirGilead has begun testing its COVID-19 coronavirus antiviral remdesivir in the UK, announcing plans to trial the drug Share XGilead begins UK trials of COVID-19 drug remdesivirhttps://pharmaphorum.com/news/gilead-begins-uk-trials-of-covid-19-drug-remdesivir/
Synairgen doses first patients with COVID-19 drugUK biotech Synairgen has started dosing patients in its phase 2 trial of SNG001, an inhaled formulation of Share XSynairgen doses first patients with COVID-19 drughttps://pharmaphorum.com/news/synairgen-doses-first-patients-with-covid-19-drug/
J&J and US government invest $1 billion in COVID-19 vaccineJohnson & Johnson has announced plans to team up with the US government to invest more than $1 Share XJ&J and US government invest $1 billion in COVID-19 vaccinehttps://pharmaphorum.com/news/jj-and-us-government-invest-1-billion-in-covid-19-vaccine/
Sanofi begins trial of Kevzara against COVID-19 complicationsSanofi and Regeneron are throwing an already-approved drug at COVID-19, testing Kevzara (sarilumab) in patients hospitalised with severe Share XSanofi begins trial of Kevzara against COVID-19 complicationshttps://pharmaphorum.com/news/sanofi-begins-trial-of-kevzara-against-covid-19-complications/
Equal coronavirus vaccine access a “real issue”Though several pharma companies are rushing to produce a vaccine for the coronavirus causing the COVID-19 pandemic, aided Share XEqual coronavirus vaccine access a “real issue”https://pharmaphorum.com/news/equal-coronavirus-vaccine-access-real-issue/
Pharma companies that don’t change during COVID-19 will be ‘new Kodaks of this world’Janssen’s former clinical innovation VP Andreas Koester has warned that pharma companies that go back to how they Share XPharma companies that don’t change during COVID-19 will be ‘new Kodaks of this world’https://pharmaphorum.com/news/pharma-companies-that-dont-change-during-covid-19-will-be-new-kodaks-of-this-world/
FDA approves AZ Imfinzi in new lung cancer useAstraZeneca has reported a double win after the FDA approved its Imfinzi for a form of lung cancer, Share XFDA approves AZ Imfinzi in new lung cancer usehttps://pharmaphorum.com/news/fda-approves-az-imfinzi-in-new-lung-cancer-use/
FDA grants emergency use of malaria drugs against COVID-19The FDA has approved emergency use of malaria drugs championed by president Donald Trump for use in patients Share XFDA grants emergency use of malaria drugs against COVID-19https://pharmaphorum.com/news/fda-grants-emergency-use-of-malaria-drugs-against-covid-19/
Sanofi inks COVID-19 mRNA vaccine deal with Translate BioSanofi’s Pasteur vaccines unit has joined with the US biotech Translate Bio to announce a partnership to develop Share XSanofi inks COVID-19 mRNA vaccine deal with Translate Biohttps://pharmaphorum.com/news/sanofi-inks-covid-19-mrna-vaccine-deal-with-translate-bio/
Takeda signs $882m rare disease alliance with Oxford biotech EvoxEvox Therapeutics is the second UK biotech to sign a big deal with a pharma giant this week, Share XTakeda signs $882m rare disease alliance with Oxford biotech Evoxhttps://pharmaphorum.com/news/takeda-signs-882m-rare-disease-alliance-with-oxford-biotech-evox/
Pharma giants including Novartis collaborate on COVID-19 therapiesA consortium of life sciences companies including pharma giants such as Novartis and Johnson & Johnson, are to Share XPharma giants including Novartis collaborate on COVID-19 therapieshttps://pharmaphorum.com/news/collaborate-covid19-therapies/
AZ adds gene silencing tech to pipeline with Silence Therapeutics dealAstraZeneca has announced a collaboration with UK biotech Silence Therapeutics to develop gene silencing drugs for cardiovascular, renal, Share XAZ adds gene silencing tech to pipeline with Silence Therapeutics dealhttps://pharmaphorum.com/news/az-adds-gene-silencing-tech-to-pipeline-with-silence-therapeutics-deal/
Celltrion to develop coronavirus antibody and fast testSouth Korea’s Celltrion has joined the many pharma companies fighting the COVID-19 coronavirus outbreak, saying it is working Share XCelltrion to develop coronavirus antibody and fast testhttps://pharmaphorum.com/news/celltrion-antibody-and-fast-test/
Novartis publishes long-term data from SMA gene therapyNovartis has produced data demonstrating its Zolgensma gene therapy produces long term benefits in the rare muscle wasting Share XNovartis publishes long-term data from SMA gene therapyhttps://pharmaphorum.com/news/novartis-publishes-long-term-data-from-sma-gene-therapy/
Oxford University prepares for coronavirus vaccine trialScientists from the University of Oxford say they have identified a potential vaccine for the SARS-CoV-2 coronavirus that Share XOxford University prepares for coronavirus vaccine trialhttps://pharmaphorum.com/news/oxford-university-prepares-for-coronavirus-vaccine-trial/
Lilly, Galapagos suspend trials as COVID-19 hits health systemsEli Lilly has said it will suspend most clinical trials for the time being in light of the Share XLilly, Galapagos suspend trials as COVID-19 hits health systemshttps://pharmaphorum.com/news/lilly-galapagos-suspend-trials-as-covid-19-hits-health-systems/
Gilead halts ‘compassionate use’ of potential coronavirus drugGilead has said it has stopped accepting “compassionate use” requests for its potential coronavirus antiviral remdesivir because it Share XGilead halts ‘compassionate use’ of potential coronavirus drughttps://pharmaphorum.com/news/gilead-halts-compassionate-use-of-potential-coronavirus-drug/
AbbVie’s Kaletra doesn’t work in COVID-19, say Chinese scientistsA clinical trial of AbbVie’s HIV therapy Kaletra conducted by researchers in China has undermined hopes it could Share XAbbVie’s Kaletra doesn’t work in COVID-19, say Chinese scientistshttps://pharmaphorum.com/news/abbvies-kaletra-doesnt-work-in-covid-19-say-chinese-scientists/
